In part one of a two-part special presentation, NOVA reports on the trials to determine whether the new drug Interleukin-2 - the first to make use of the body's own disease-fighting strategy - will live up to its promise as a pivotal cancer breakthrough. Jane Pauley of NBC News hosts and narrates.